CN109619089B - 一种胰岛细胞低温保存液及其使用方法 - Google Patents
一种胰岛细胞低温保存液及其使用方法 Download PDFInfo
- Publication number
- CN109619089B CN109619089B CN201811610661.0A CN201811610661A CN109619089B CN 109619089 B CN109619089 B CN 109619089B CN 201811610661 A CN201811610661 A CN 201811610661A CN 109619089 B CN109619089 B CN 109619089B
- Authority
- CN
- China
- Prior art keywords
- cells
- islet
- low
- mesenchymal stem
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004153 islets of langerhan Anatomy 0.000 title claims abstract description 89
- 239000003761 preservation solution Substances 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims abstract description 29
- 239000003636 conditioned culture medium Substances 0.000 claims abstract description 25
- 239000001963 growth medium Substances 0.000 claims abstract description 21
- WRDABNWSWOHGMS-UHFFFAOYSA-N AEBSF hydrochloride Chemical compound Cl.NCCC1=CC=C(S(F)(=O)=O)C=C1 WRDABNWSWOHGMS-UHFFFAOYSA-N 0.000 claims abstract description 16
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000004321 preservation Methods 0.000 claims abstract description 15
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 12
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 12
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 12
- DBLXOVFQHHSKRC-UHFFFAOYSA-N ethanesulfonic acid;2-piperazin-1-ylethanol Chemical compound CCS(O)(=O)=O.OCCN1CCNCC1 DBLXOVFQHHSKRC-UHFFFAOYSA-N 0.000 claims abstract description 11
- 210000004027 cell Anatomy 0.000 claims description 53
- 238000003860 storage Methods 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 25
- 238000005138 cryopreservation Methods 0.000 claims description 18
- 239000002609 medium Substances 0.000 claims description 11
- 210000002966 serum Anatomy 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 239000012980 RPMI-1640 medium Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 7
- 238000007710 freezing Methods 0.000 claims description 6
- 230000008014 freezing Effects 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 4
- 230000001640 apoptogenic effect Effects 0.000 claims description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
- 235000018417 cysteine Nutrition 0.000 claims description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 230000001464 adherent effect Effects 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 2
- 239000007640 basal medium Substances 0.000 claims 3
- 210000001808 exosome Anatomy 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 235000003642 hunger Nutrition 0.000 claims 1
- 230000037351 starvation Effects 0.000 claims 1
- 230000004083 survival effect Effects 0.000 description 13
- 241000282887 Suidae Species 0.000 description 11
- 238000010586 diagram Methods 0.000 description 11
- 239000000654 additive Substances 0.000 description 9
- 230000000996 additive effect Effects 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000005779 cell damage Effects 0.000 description 3
- 208000037887 cell injury Diseases 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 102000004121 Annexin A5 Human genes 0.000 description 2
- 108090000672 Annexin A5 Proteins 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000002577 cryoprotective agent Substances 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000002631 hypothermal effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002689 xenotransplantation Methods 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002338 cryopreservative effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000037890 multiple organ injury Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811610661.0A CN109619089B (zh) | 2018-12-27 | 2018-12-27 | 一种胰岛细胞低温保存液及其使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811610661.0A CN109619089B (zh) | 2018-12-27 | 2018-12-27 | 一种胰岛细胞低温保存液及其使用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109619089A CN109619089A (zh) | 2019-04-16 |
CN109619089B true CN109619089B (zh) | 2020-04-21 |
Family
ID=66078312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811610661.0A Active CN109619089B (zh) | 2018-12-27 | 2018-12-27 | 一种胰岛细胞低温保存液及其使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109619089B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110367242A (zh) * | 2019-08-02 | 2019-10-25 | 陕西佰傲干细胞再生医学有限公司 | 凋亡小体保存液及凋亡小体的保存方法 |
CN112251397B (zh) * | 2020-10-30 | 2022-02-15 | 湖南赛诺生物科技股份有限公司 | 一种新生猪胰岛细胞培养方法 |
CN112715533B (zh) * | 2021-02-26 | 2022-04-29 | 康妍葆(北京)干细胞科技有限公司 | 一种间充质干细胞的冻存液及冻存方法 |
CN114868736B (zh) * | 2022-03-08 | 2022-12-09 | 四川中科奥格生物科技有限公司 | 一种胰岛细胞稳定液及其制备方法和用途 |
CN114831107B (zh) * | 2022-04-11 | 2023-02-24 | 苏州依科赛生物科技股份有限公司 | 一种细胞和组织低温保存液及其配制方法、应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102197802A (zh) * | 2011-03-25 | 2011-09-28 | 中国人民解放军南京军区福州总医院 | 一种胰岛冻存保护剂及其使用方法 |
CN105850979A (zh) * | 2016-03-14 | 2016-08-17 | 广州赛莱拉干细胞科技股份有限公司 | 一种骨髓间充质干细胞的冻存保护液及冻存方法 |
CN106982822A (zh) * | 2017-05-24 | 2017-07-28 | 湖南赛诺生物科技股份有限公司 | 一种猪胰岛细胞冻存液及冻存方法 |
-
2018
- 2018-12-27 CN CN201811610661.0A patent/CN109619089B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102197802A (zh) * | 2011-03-25 | 2011-09-28 | 中国人民解放军南京军区福州总医院 | 一种胰岛冻存保护剂及其使用方法 |
CN105850979A (zh) * | 2016-03-14 | 2016-08-17 | 广州赛莱拉干细胞科技股份有限公司 | 一种骨髓间充质干细胞的冻存保护液及冻存方法 |
CN106982822A (zh) * | 2017-05-24 | 2017-07-28 | 湖南赛诺生物科技股份有限公司 | 一种猪胰岛细胞冻存液及冻存方法 |
Non-Patent Citations (2)
Title |
---|
"Improvement of Human Islet Cryopreservation by a p38 MAPK Inhibito";K. Omori等;《American Journal of Transplantation》;20071231;第7卷(第5期);第1224-1232页 * |
"Islet cryopreservation: Improved recovery following taurine pretreatment";Hardikar, AA等;《CELL TRANSPLANTATION》;20011231;第10卷(第3期);第247-253页 * |
Also Published As
Publication number | Publication date |
---|---|
CN109619089A (zh) | 2019-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109619089B (zh) | 一种胰岛细胞低温保存液及其使用方法 | |
CN110050782B (zh) | 一种干细胞冻存液及其制备方法和冻存方法 | |
US7112576B1 (en) | Compositions and methods for cryopreservation of peripheral blood lymphocytes | |
TWI773693B (zh) | 從臍帶的羊膜分離間質幹細胞的方法、從臍帶的羊膜分離的間質幹細胞群以及用於從臍帶的羊膜分離間質幹細胞的細胞培養基 | |
CN107027743B (zh) | 细胞冻存液及细胞冻存方法 | |
Gouk et al. | Cryopreservation of mouse testicular tissue: prospect for harvesting spermatogonial stem cells for fertility preservation | |
US5827741A (en) | Cryopreservation of human adult and fetal pancreatic cells and human platelets | |
US5679565A (en) | Method of preserving pancreatic islets | |
CN109090100A (zh) | 一种间充质干细胞冻存液及其制备方法与使用方法 | |
Buchanan et al. | Preservation of differentiation and clonogenic potential of human hematopoietic stem and progenitor cells during lyophilization and ambient storage | |
JP2008528034A (ja) | 直ぐに利用可能な臍帯血から誘導される細胞物質、及びその組成物の提供方法 | |
CN109892319B (zh) | 一种用于猪胰岛细胞的冻存复苏方法及冻存液和复苏液 | |
EP0237863A1 (en) | Synthetic, plasma-free, transfusible platelet storage medium. | |
EP2271208A1 (en) | Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue | |
CN105941389A (zh) | 一种无动物源血清的细胞冻存液 | |
CN111602648B (zh) | 一种免疫细胞无血清冻存液及冻存方法 | |
CN111838139A (zh) | 一种无蛋白细胞冻存液及其应用 | |
CN112450206A (zh) | 一种直接静脉使用的非程序细胞冻存液 | |
CN107711823B (zh) | 一种常温保存的细胞冻存液及其应用 | |
WO1998014058A1 (en) | Cryopreservation of human adult and fetal pancreatic cells and human platelets | |
US8642315B2 (en) | Process for preserving insulin-secreting cells intended to be transplanted in a patient | |
CN112251397B (zh) | 一种新生猪胰岛细胞培养方法 | |
CN113133445B (zh) | 一种间充质干细胞的保存方法、运输方法及其处理方法 | |
Marlicz et al. | Isolation of hematopoietic stem cells from heparinized cadaveric multiple organ donors: Potential clinical implications | |
CN111374123B (zh) | 中性氨基酸作为细胞低温保护剂的使用方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A cryopreservation solution for islet cells and its application method Effective date of registration: 20201229 Granted publication date: 20200421 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2020980010070 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230105 Granted publication date: 20200421 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2020980010070 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A cryopreservation solution for islet cells and its use method Effective date of registration: 20230112 Granted publication date: 20200421 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2023980031055 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231124 Granted publication date: 20200421 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2023980031055 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A low-temperature preservation solution for pancreatic islet cells and its usage method Effective date of registration: 20231129 Granted publication date: 20200421 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2023980068297 |